Search

everythinglearnresearchcommunity

for

Search:↓

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

EGF controls hair growth by regulating hair follicles' growth phases.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Cetuximab can cause eyelash growth, which is rare but manageable.

Targeted cancer therapies often cause serious skin problems that need careful management.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Pilose antler extracts help hair growth by activating hair follicle stem cells.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

New therapies are being developed that target integrin pathways to treat various diseases.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Gray hair can potentially be reversed, leading to new treatments.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Different signals work together to change gene activity and guide hair follicle stem cells to become specific cell types.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

Testosterone is crucial for development, growth, and various body functions in mammals.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.